Impact of fetal echocardiography

Annals of Pediatric Cardiology

Volumn 2, Issue 1, 2009, Pages 41-50

  Simpson, John ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Congenital heart disease; Echocardiography; Fetal heart

Indexed keywords

AORTA COARCTATION; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; ECHOCARDIOGRAPHY; FETUS ECHOGRAPHY; FETUS ELECTROCARDIOGRAPHY; FETUS HEART; GREAT VESSELS TRANSPOSITION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MORBIDITY; MORTALITY; NUCHAL TRANSLUCENCY MEASUREMENT; OUTCOME ASSESSMENT; PRENATAL DIAGNOSIS; PROGNOSIS; REVIEW; RISK FACTOR; SCREENING;

EID: 77953387882     PISSN: 09742069     EISSN: 09745149     Source Type: Journal    
DOI: 10.4103/0974-2069.52806     Document Type: Review

References (63)

1. Allan LD, Sharland GK, Milburn A, Lockhart SM, Groves AM, Anderson RH, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994;23:1452-8.
2. Allan L, Dangel J, Fesslova V, Marek J, Mellander M, Oberhänsli I, et al. Recommendations for the practice of fetal cardiology in Europe. Cardiol Young 2004;14:109-14.
3. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet 1999;354:1242-7 ik.
4. Sharland G. Fetal cardiology. Semin Neonatol 2001;6:3-15.
5. Sharland G. What should be provided by a service for fetal cardiology? Cardiol Young 2000;10:625-35.
6. Stoll C, Garne E, Clementi M; EUROSCAN Study Group. Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe. Prenat Diagn 2001;21:243-52.
7. Garne E, Stoll C, Clementi M; Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: Experience from 20 European registries. Ultrasound Obstet Gynecol 2001;17:386-91.
8. Garne E, Berghold A, Johnson Z, Stoll C. Different policies on prenatal ultrasound screening programmes and induced abortions explain regional variations in infant mortality with congenital malformations. Fetal Diagn Ther 2001;16:153-7.
9. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study. BMJ 1999;318:81-5.
10. Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005;26:154-7.
11. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001;18:610-4.
12. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B, et al. Limitations of using frst-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17:106-10.
13. Michailidis GD, Spencer K, Economides DL. The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's syndrome. BJOG 2001;108:1047-52.
14. Makrydimas G, Sotiriadis A, Huggon IC, Simpson J, Sharland G, Carvalho JS, et al. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005;192:89-95.
15. Simpsom JM, Jones A, Callaghan N, Sharland GK. Accuracy and limitations of transabdominal fetal echocardiography at 12-15 weeks of gestation in a population at high risk for congenital heart disease. BJOG 2000;107:1492-7.
16. Carvalho JS, Moscoso G, Ville Y. First-trimester transabdominal fetal echocardiography. Lancet 1998;351:1023-7.
17. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identifed prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002;20:22-9.
18. Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103:1269-73.
19. Kumar RK, Newburger JW, Gauvreau K, Kamenir SA, Hornberger LK. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol 1999;83:1649-53.
20. Mahle WT, Clancy RR, McGaurn SP, Goin JE, Clark BJ. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics 2001;107:1277-82.
21. Bonnet D, Coltri A, Butera G, Fermont L, Le Bidois J, Kachaner J, Sidi D, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99:916-8.
22. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002;87: 67-9.
23. Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994;71:3-7.
24. Tzifa A, Barker C, Tibby SM, Simpson JM. Prenatal diagnosis of pulmonary atresia: Impact on clinical presentation and early outcome. Arch Dis Child Fetal Neonatal Ed 2007;92:F199-203.
25. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003;89:913-7.
26. Simpson JM, Sharland GK. Fetal tachycardias: Management and outcome of 127 consecutive cases. Heart 1998;79:576-81.
27. van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P, et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5.
28. Fouron JC. Fetal arrhythmias: The Saint-Justine hospital experience. Prenat Diagn 2004;24:1068-80.
29. Simpson JM. Fetal arrhythmias. Ultrasound Obstet Gynecol 2006;27:599-606.
30. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: A multicenter experience. J Am Coll Cardiol 1991;17:1360-6.
31. Lopes LM, Tavares GM, Damiano AP, Lopes MA, Aiello VD, Schultz R, et al. Perinatal outcome of fetal atrioventricular block: One-hundred-sixteen cases from a single institution. Circulation 2008;118:1268-75.
32. Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron JC. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: Combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 2005;26:16-21.
33. Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M, et al. Atrioventricular block detected in fetal life: Associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 2005;26:4-15.
34. Groves AM, Allan LD, Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 1995;92:3394-6.
35. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996;75:190-4.
36. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004;110:1542-8.
37. Rosenthal E, Gordon PA, Simpson JM, Sharland GK. Letter regarding article by Jaeggi et al. "transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease". Circulation 2005;111:e287-8 author reply e287-8.
38. Maxwell D, Allan L, Tynan MJ. Balloon dilatation of the aortic valve in the fetus: A report of two cases. Br Heart J 1991;65:256-8.
39. Kohl T, Sharland G, Allan LD, Gembruch U, Chaoui R, Lopes LM, et al. World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol 2000;85:1230-3.
40. Tworetzky W, Wilkins-Haug L, Jennings RW, van der Velde ME, Marshall AC, Marx GR, et al. Balloon dilation of severe aortic stenosis in the fetus: Potential for prevention of hypoplastic left heart syndrome: Candidate selection, technique, and results of successful intervention. Circulation 2004;110:2125-31.
41. Tulzer G, Arzt W, Franklin RC, Loughna PV, Mair R, Gardiner HM. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 2002;360:1567-8.
42. Marshall AC, van der Velde ME, Tworetzky W, Gomez CA, Wilkins-Haug L, Benson CB, et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 2004;110:253-8.
43. McCaffrey FM, Sherman FS. Prenatal diagnosis of severe aortic stenosis. Pediatr Cardiol 1997;18:276-81.
44. Simpson JM, Sharland GK. Natural history and outcome of aortic stenosis diagnosed prenatally. Heart 1997;77:205-10.
45. Makikallio K, McElhinney DB, Levine JC, Marx GR, Colan SD, Marshall AC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: Patient selection for fetal intervention. Circulation 2006;113:1401-5.
46. Viñals F, Heredia F, Giuliano A. The role of the three vessels and trachea view (3VT) in the diagnosis of congenital heart defects. Ultrasound Obstet Gynecol 2003;22:358-67.
47. Yagel S, Cohen SM, Achiron R. Examination of the fetal heart by fve short-axis views: A proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001;17:367-9.
48. Yagel S, Arbel R, Anteby EY, Raveh D, Achiron R. The three vessels and trachea view (3VT) in fetal cardiac scanning. Ultrasound Obstet Gynecol 2002;20:340-5.
49. Lee W, Allan L, Carvalho JS, Chaoui R, Copel J, Devore G, et al. ISUOG consensus statement: What constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008;32:239-42.
50. Carvalho JS, Ho SY, Shinebourne EA. Sequential segmental analysis in complex fetal cardiac abnormalities: A logical approach to diagnosis. Ultrasound Obstet Gynecol 2005;26:105-11.
51. Hunter S, Heads A, Wyllie J, Robson S. Prenatal diagnosis of congenital heart disease in the northern region of England: Benefts of a training programme for obstetric ultrasonographers. Heart 2000;84:294-8.
52. Sharland GK, Allan LD. Screening for congenital heart disease prenatally. Results of a 21/2-year study in the South East Thames Region. Br J Obstet Gynaecol 1992;99:220-5.
53. Pézard P, Bonnemains L, Boussion F, Sentilhes L, Allory P, Lépinard C, et al. Infuence of ultrasonographers training on prenatal diagnosis of congenital heart diseases: A 12-year population-based study. Prenat Diagn 2008;28:1016-22.
54. Tegnander E, Eik-Nes SH. The examiner's ultrasound experience has a signifcant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. Ultrasound Obstet Gynecol 2006;28:8-14.
55. Rustico MA, Benettoni A, D'Ottavio G, Fischer-Tamaro L, Conoscenti GC, Meir Y, et al. Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: The role of operator experience. Ultrasound Obstet Gynecol 2000;16:614-9.
56. Stümpfen I, Stümpfen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996;348:854-7.
57. Buskens E, Grobbee DE, Frohn-Mulder IM, Stewart PA, Juttmann RE, Wladimiroff JW, et al. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation 1996;94:67-72.
58. Chaoui R, Hoffmann J, Heling KS. Three-dimensional (3D) and 4D color Doppler fetal echocardiography using spatio-temporal image correlation (STIC). Ultrasound Obstet Gynecol 2004;23:535-45.
59. Viñals F, Poblete P, Giuliano A. Spatio-temporal image correlation (STIC): A new tool for the prenatal screening of congenital heart defects. Ultrasound Obstet Gynecol 2003;22:388-94.
60. DeVore GR, Falkensammer P, Sklansky MS, Platt LD. Spatio-temporal image correlation (STIC): New technology for evaluation of the fetal heart. Ultrasound Obstet Gynecol 2003;22:380-7.
61. Wanitpongpan P, Kanagawa T, Kinugasa Y, Kimura T. Spatio-temporal image correlation (STIC) used by general obstetricians is marginally clinically effective compared to 2D fetal echocardiography scanning by experts. Prenat Diagn 2008;28:923-8.
62. Viñals F, Mandujano L, Vargas G, Giuliano A. Prenatal diagnosis of congenital heart disease using four-dimensional spatio-temporal image correlation (STIC) telemedicine via an Internet link: A pilot study. Ultrasound Obstet Gynecol 2005;25:25-31.
63. Michailidis GD, Simpson JM, Karidas C, Economides DL. Detailed three-dimensional fetal echocardiography facilitated by an Internet link. Ultrasound Obstet Gynecol 2001;18:325-8.